Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Clinical trial NCT05611931 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05611931
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2026-08-01
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.